Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, New York.
Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York.
Fertil Steril. 2017 Aug;108(2):357-360. doi: 10.1016/j.fertnstert.2017.05.025. Epub 2017 Jun 16.
To report a case of ex vivo oocyte retrieval from oophorectomized specimens in a BRCA1 mutation carrier undergoing surgical staging for ovarian cancer.
Video case report and literature review.
University-affiliated center.
PATIENT(S): A 37-year-old single woman, gravida 0, with a known BRCA1 mutation, presented to her oncologist with a complex right ovarian mass and elevated CA-125 level. Ovarian cancer was suspected, and the patient consented to complete surgical staging. Although she desired to cryopreserve oocytes for fertility preservation, conventional oocyte retrieval was deemed unsafe because follicular puncture would compromise the integrity of the ovarian capsule, thereby increasing the risk of malignant cell spillage and cancer upstaging.
INTERVENTION(S): Luteal-phase ovarian stimulation with gonadotropins and letrozole was performed. Surgical staging was initiated 34 hours after the administration of the ovulatory trigger.
MAIN OUTCOME MEASURE(S): Ex vivo retrieval of oocytes from bilateral oophorectomized specimens under direct visualization at the time of surgical staging.
RESULT(S): Seven mature oocytes were retrieved and vitrified. Concomitant surgical staging was completed.
CONCLUSION(S): The present case highlights the feasibility of ex vivo or extracorporeal retrieval of mature oocytes from oophorectomized specimens in patients with ovarian cancer. By avoiding follicular puncture within the pelvic cavity, it minimizes the risk of malignant cell spillage and cancer upstaging.
报告一例 BRCA1 基因突变携带者在接受卵巢癌手术分期时,从已切除的卵巢组织中进行离体卵母细胞获取的病例。
视频病例报告和文献复习。
大学附属医院。
一名 37 岁的单身女性,初产妇 0 级,携带已知的 BRCA1 基因突变,因右侧卵巢肿块伴 CA-125 水平升高就诊于肿瘤医生。怀疑为卵巢癌,患者同意进行全面的手术分期。尽管她希望通过冷冻保存卵母细胞来保留生育能力,但传统的卵母细胞获取被认为是不安全的,因为卵泡穿刺会破坏卵巢包膜的完整性,从而增加恶性细胞外溢和癌症升级的风险。
在黄体期用促性腺激素和来曲唑进行卵巢刺激。排卵触发后 34 小时开始进行手术分期。
在手术分期时直接可视化的情况下,从双侧已切除的卵巢标本中离体获取卵母细胞。
共获取并冷冻了 7 个成熟卵母细胞。同时完成了手术分期。
本病例强调了在卵巢癌患者中,从已切除的卵巢组织中进行离体或体外成熟卵母细胞获取的可行性。通过避免在盆腔内进行卵泡穿刺,可以最大限度地降低恶性细胞外溢和癌症升级的风险。